Authors:
Risch, HA
McLaughlin, JR
Cole, DEC
Rosen, B
Bradley, L
Kwan, E
Jack, E
Vesprini, DJ
Kuperstein, G
Abrahamson, JLA
Fan, I
Wong, B
Narod, SA
Citation: Ha. Risch et al., Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer, AM J HU GEN, 68(3), 2001, pp. 700-710
Authors:
de los Rios, P
Jack, E
Kuperstein, G
Lynch, H
Lubinski, J
Narod, SA
Citation: P. De Los Rios et al., Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer, AM J HU GEN, 68(2), 2001, pp. 546-546
Authors:
Kuperstein, G
Foulkes, WD
Ghadirian, P
Hakimi, J
Narod, SA
Citation: G. Kuperstein et al., A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes, CLIN GENET, 57(3), 2000, pp. 213-220
Authors:
Avigad, S
Kuperstein, G
Zilberstein, J
Liberzon, E
Stark, B
Gelernter, I
Kodman, Y
Luria, D
Ash, S
Stein, J
Goshen, Y
Yaniv, I
Cohen, IJ
Zaizov, R
Citation: S. Avigad et al., TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia, LEUKEMIA, 13(3), 1999, pp. 481-483